Articles
Original reporting and explainers on the science and business of living longer.
Breakthroughs
Insider Briefing: Longevity Clinical Trials Worth Watching Right Now
A working shortlist of active human trials in the senolytic, rapamycin-analog, and reprogramming spaces, and what would have to happen for each to actually matter.
Belief & Meaning
When Silicon Valley Gets Religious About Not Dying
Some of the most serious money in longevity comes wrapped in something closer to faith than science. Here's where the pursuit of immortality turns spiritual — on purpose.
The Wealthy Pursuit
Uploading Your Mind: The Bet That Consciousness Is Just Data
A serious, well-funded slice of the longevity world isn't trying to keep your body alive at all — it's trying to get "you" out of it before it fails.
Breakthroughs
Stem Cells, Cryonics, and the Drugs That Might Slow Aging: What People Are Actually Trying
From frozen bodies to repurposed diabetes drugs, here's what the people betting on medicine to beat aging are actually doing — and how far each bet really is from proven.
The Wealthy Pursuit
The Billionaire Bet on Immortality
A wave of biotech ventures backed by ultra-wealthy founders has poured billions into aging research. What are they actually funding, and why does it matter to everyone else?
Breakthroughs
What's Already Been Done: A Century of Quiet Life Extension
Before gene therapy and senolytics, public health and medicine had already added decades to average life expectancy. It's worth remembering how.
Overview
The State of the Science: Where Longevity Research Stands Today
Aging is increasingly treated as a set of measurable, targetable biological processes rather than an inevitability. Here's where the research actually stands.